Filing Summary
Registrant: Xperi Holding Corporation (the request identifies Adeia Inc.; the filing itself names Xperi Holding Corporation). The Form 8-K reports results of the company’s 2022 Annual Meeting of Stockholders held April 29, 2022, and was filed May 2, 2022.
Business Context and Reporting Period
This filing concerns corporate governance, equity-plan approvals, executive compensation approval, and auditor ratification. It does not report quarterly or annual operating results.
Key Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating and financial metrics.
Material Changes and Meeting Results
- All eight director nominees were elected: Darcy Antonellis, Laura J. Durr, David C. Habiger, Jon Kirchner, Daniel Moloney, Tonia O’Connor, Raghavendra Rau, and Christopher A. Seams.
- The 2020 Equity Incentive Plan was amended to reserve an additional 8,800,000 shares of common stock.
- The 2020 Employee Stock Purchase Plan was amended to reserve an additional 6,000,000 shares of common stock.
- Stockholders approved, on an advisory basis, the compensation of the named executive officers.
- Stockholders ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
Vote Highlights
| Proposal | For | Against | Abstain | Broker Non-Votes |
|---|---|---|---|---|
| Equity Incentive Plan amendment | 79,607,308 | 6,203,838 | 83,433 | 10,536,337 |
| Employee Stock Purchase Plan amendment | 82,883,811 | 2,939,739 | 71,029 | 10,536,337 |
| Advisory executive compensation approval | 65,031,170 | 20,803,298 | 60,111 | 10,536,337 |
| Auditor ratification | 94,613,343 | 1,751,621 | 65,952 | Not applicable |
Guidance, Outlook, Risks, and Unusual Items
The filing provides no financial guidance or management outlook. The principal potentially dilutive items are the additional 8.8 million shares authorized under the equity incentive plan and 6.0 million shares authorized under the employee stock purchase plan. The relatively high opposition vote on executive compensation should be monitored, although the approval was advisory and nonbinding.
Investor Verification Items
- Confirm the registrant’s identity and any subsequent corporate name or restructuring changes, given the discrepancy between the requested company name and the filing’s stated name.
- Review the detailed terms of the amended equity incentive and employee stock purchase plans, including potential dilution and vesting or purchase provisions.
- Monitor future stock-based compensation expense and share-count effects.
- Review subsequent proxy materials for the company’s response to the level of opposition to executive compensation.